Your browser doesn't support javascript.
loading
Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.
Glicksman, Rachel M; Loblaw, Andrew; Morton, Gerard; Szumacher, Ewa; Chung, Hans T; Vesprini, Danny; Chu, William; Liu, Stanley K; Choo, Richard; Deabreu, Andrea; Mamedov, Alexandre; Zhang, Liying; Cheung, Patrick.
Afiliación
  • Glicksman RM; Department of Radiation Oncology, University of Toronto, Canada.
  • Loblaw A; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Morton G; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Szumacher E; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Chung HT; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Vesprini D; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Chu W; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Liu SK; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Choo R; Department of Radiation Oncology, Mayo Clinic, Rochester, United States.
  • Deabreu A; Clinical Trials and Epidemiology Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Mamedov A; Clinical Trials and Epidemiology Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Zhang L; Clinical Trials and Epidemiology Program, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Cheung P; Department of Radiation Oncology, University of Toronto, Canada; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada. Electronic address: Patrick.cheung@sunnybrook.ca.
Radiother Oncol ; 163: 21-31, 2021 10.
Article en En | MEDLINE | ID: mdl-34324914

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia de Intensidad Modulada Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Radioterapia de Intensidad Modulada Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Radiother Oncol Año: 2021 Tipo del documento: Article País de afiliación: Canadá